This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Roble Bedolla: Innovator in Cancer Research
Introduction
Roble Bedolla is a notable inventor based in San Antonio, Texas, recognized for his contributions to cancer research. His innovative work focuses on methods for assessing cancer recurrence, particularly in prostate cancer patients. With a commitment to advancing medical science, Bedolla has made significant strides in identifying high-risk individuals for prostate cancer recurrence.
Latest Patents
Roble Bedolla holds a patent for "Methods for assessing cancer recurrence." This patent outlines specific methods for identifying subjects at a higher risk of prostate cancer recurrence. The innovative approach involves measuring levels of FLIP, transcription factor Sp1, and transcription factor Sp3 in prostate samples. Elevated levels of these markers indicate a higher risk for recurrence, providing valuable insights for patient management.
Career Highlights
Bedolla is affiliated with the University of Texas System, where he continues to contribute to groundbreaking research in oncology. His work not only enhances the understanding of cancer recurrence but also aids in developing targeted treatment strategies for patients.
Collaborations
Throughout his career, Roble Bedolla has collaborated with esteemed colleagues, including Izhar Singh Batth and Rita Ghosh. These partnerships have fostered a collaborative environment that promotes innovative research and development in cancer diagnostics.
Conclusion
Roble Bedolla's contributions to cancer research exemplify the impact of innovation in medicine. His patented methods for assessing cancer recurrence are crucial for improving patient outcomes and advancing the field of oncology.